跳至主要内容
临床试验/NCT05627596
NCT05627596已完成2 期

Effectiveness of Nicotine Replacement Therapy Sampling in Dental Practices

Sandra Japuntich1 个研究点 分布在 1 个国家目标入组 1,239 人开始时间: 2023年6月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
1,239
试验地点
1
主要终点
7-day biochemically confirmed point prevalence abstinence

研究概览

简要总结

The Free Samples for Health (FreSH) study tests whether providing free samples of stop smoking medicine called nicotine replacement therapy at dental visits results in a greater number of people quitting smoking than providing a gift of equal value (an electric toothbrush).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years old
  • smokes at least 1 combustible cigarette per day on at least 25 days of the month

排除标准

  • does not own a smartphone with internet access
  • myocardial infarction or stroke in the past 3 months
  • pregnant or breastfeeding
  • use of tobacco cessation medication in the past week

研究组 & 干预措施

Nicotine Replacement Therapy

Experimental

Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and a two week supply of 14mg nicotine patches and 4mg lozenges.

干预措施: Nicotine lozenge (Drug)

Electric Toothbrush

Active Comparator

Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and an electric toothbrush.

干预措施: Ask-Advise-Refer (Behavioral)

Nicotine Replacement Therapy

Experimental

Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and a two week supply of 14mg nicotine patches and 4mg lozenges.

干预措施: Ask-Advise-Refer (Behavioral)

Nicotine Replacement Therapy

Experimental

Participants will receive the Ask-Advise-Refer intervention which includes an oral health practitioner asking about their tobacco use, advising them to quit smoking, and referring them to the state quitline. They will also receive a sample bag including information about smoking and oral health, the state quitline, and a two week supply of 14mg nicotine patches and 4mg lozenges.

干预措施: Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release (Drug)

结局指标

主要结局

7-day biochemically confirmed point prevalence abstinence

时间窗: 6 months post baseline

Proportion reporting no smoking in the 7 days prior to the 6-month follow-up timepoint and having an exhaled carbon monoxide value of less than 6 parts per million

7-day Biochemically Confirmed Point Prevalence Abstinence

时间窗: 6 months post baseline

Percentage reporting no smoking in the 7 days prior to the 6-month follow-up timepoint and having an exhaled carbon monoxide value of less than 6 parts per million

次要结局

  • 7-day self-reported point prevalence abstinence(1 month post baseline)
  • 24-hour intentional quit attempts(6 months post baseline)
  • Smoking heaviness(6 months post baseline)
  • Nicotine replacement therapy utilization(6 months post baseline)
  • Perceived nicotine replacement therapy safety(6 months post baseline)
  • Perceived nicotine replacement therapy efficacy(6 months post baseline)
  • 7-day Self-reported Point Prevalence Abstinence(1 month post baseline)
  • 7-day Self-reported Point Prevalence Abstinence(3 months post baseline)
  • 24-hour Intentional Quit Attempts(6 months post baseline)
  • Smoking Heaviness(6 months post baseline)
  • Nicotine Replacement Therapy Utilization(6 months post baseline)
  • Perceived Nicotine Replacement Therapy Safety(6 months post baseline)
  • Perceived Nicotine Replacement Therapy Efficacy(6 months post baseline)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sandra Japuntich

Sandra Japuntich, Ph.D., L.P.

Hennepin Healthcare Research Institute

研究点 (1)

Loading locations...

相似试验